Your search matched 49 results
Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
At a time when most clinicians are overwhelmed and overworked, Microsoft and GE Healthcare are partnering together to help ease the burden of patient monitoring with a new cloud-based tool.
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
Patients are often at risk when presented with mixed messages.
Part I of a Syneos Health Series on New Oncology Commercialization Strategies
You might want to think twice about ignoring that call from a random number.
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.
MM&M eBook: Marketing in a Crisis | In The Media
In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."
At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.
In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.
Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.
Understanding the impact that telemedicine has had on HCP behaviors including prescribing in the changing COVID-19 landscape.
Peer To Peer Insights in the COVID-19 Era and Beyond | Perspectives
COVID-19 has introduced an era of unprecedented events to industries across the globe.
Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.
As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.
Recommendations for activities to inform and engage
The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.
COVID-19 has accelerated the rate at which we’re seeing change happening around us.